Skip to content

DR. CHRISTOPHE LEBRUN

Active
Private limited companyfounded 2015active for 11 yearsBegijnenhoefstraat 20, 2360 Oud-Turnhout, BelgiumKBO/BCE: BE 0628.895.045
Summary

DR. CHRISTOPHE LEBRUN has been active since 2015 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €19,292 and a net result of €45,190. Equity fluctuates too strongly from year to year to read a trend from it. Its solvency ranks better than 16% of 20,706 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).

Overview

Official details

Source: KBO
Status
Active since 27-04-2015 Normal situation
Activity
Specialist medical practice NACE 86220
Establishment unit
2.242.071.460 2360 Oud-Turnhout, since 27-04-2015
Financial year end
31 December
Peppol
Reachable since 10-12-2025

Board and ownership

Board
  • Lebrun Christophe DanielDirector

Financial position

91 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.1%
Annual accounts 2025
Gross margin
€63,459
▼ 67.1%
Turnover
≈ €140,000
estimated
Profit
€45,190
▼ 61.7%
Equity
€19,292
▼ 87.1%
Total assets
€135,974
▼ 28.2%
Score breakdownraises riskEquity €19,292 (14.2% of total assets)lowers riskSector: Human health activities (NACE 86)Size: total assets €135,974Figures for financial year 2025 (filed on 01-07-2026)Show the evidence

Checked score

Score 2025
91 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 26% of micro companies in human health (NACE 86)
Financial strength · tick: 2024
Average
Solvency 39-61
equity 14.2% of total assets
Liquidity 21-52
short-term debt 84.7% · cash 14.0%
Profitability 100=
return on assets 33.2%
Bankruptcy probability within 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,160 companies, NACE 86, micro)
Last 24 months 12-2024: < 0.1% 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: 0.1%▲ +0.1 percentage points vs 07-2025highest value 09-2025: < 0.1%▼ -0.1 percentage points vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025lowest value 11-2025: < 0.1%● unchanged vs 10-2025lowest value 12-2025: < 0.1%● unchanged vs 11-2025lowest value 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: 0.1%▲ +0.1 percentage points vs 07-2026 09-2026: 0.1%● unchanged vs 08-2026 10-2026: 0.1%● unchanged vs 09-2026 11-2026: 0.1%● unchanged vs 10-2026
Credit of up to €1,500 on 30-day terms is acceptable
Liquidity is tight, with a current ratio of 1.1 (4.38 in 2024), below the usual 1.5. Short-term debt is 84.7% and cash 14% of total assets. 85.8% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 17% of them on solvency, 3% on liquidity, 80% on profitability and 6% on growth.

The bankruptcy probability was computed on 02-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Six signals.
lowers riskraises riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Size: total assets €135,974
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
raises risk · Equity €19,292 (14.2% of total assets)
NBB · annual accounts
lowers risk · Figures for financial year 2025 (filed on 01-07-2026)
NBB · annual accounts
raises risk · Weak solvency compared with the sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 16% of 20706 sector peers (2025).
NBB · sector comparison
Position among 20706 sector peers
Solvency
better than 16%
← weakest strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 01-07-2026, 30 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
30 days early
2024
1 day early
2023
26 days early
2022
20 days early
2021
23 days late
2020
29 days early
2019
on the day
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 12 days before the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 11 July (4 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
03-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Caution: Equity fell in 2025from €149,101 to €19,292 ▼ 87.1% View
  • Caution: Lower solvency than 83% of companies in human healthsector median 63.0% · 20,706 companies 14.2% View
  • Positive: 8 profitable years in a rowprofit 2025: €45,190 8 years View
  • Positive: Filed on time since financial year 2022accounts within the deadline every year 4 years View

Recent changes

  1. · Gazette deed Incorporation
All 18 events

Comparable companies

These companies have the same main activity as DR. CHRISTOPHE LEBRUN: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €121,000 and €149,000, founded between 2014 and 2017.

CompanyTotal assetsGross margin
DR. CHRISTOPHE LEBRUN Oud-Turnhout€135,974€63,459
AUSLOOS MEDICAL Thimister-Clermont€141,096€62,833
SOCIETE NEUROLOGIE CLAES Rouvroy€138,961€62,949
Dr. Vanderlinden Esther anatoom-patholoog Wemmel€120,848€65,135
BLANCHE Kinrooi€130,690€56,937
DOCTEUR DROPSY INGRID Namur€128,640€56,699
Dokter Hans Baeten Brasschaat€148,556€53,206
Full comparison

Key facts about DR. CHRISTOPHE LEBRUN

What is the company number of DR. CHRISTOPHE LEBRUN?
The company number of DR. CHRISTOPHE LEBRUN is 0628.895.045. The VAT number is the same number with BE in front: BE 0628.895.045.
Where is DR. CHRISTOPHE LEBRUN based?
The registered office is at Begijnenhoefstraat 20, 2360 Oud-Turnhout.Company details
What does DR. CHRISTOPHE LEBRUN do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of DR. CHRISTOPHE LEBRUN?
The legal form of DR. CHRISTOPHE LEBRUN is Private limited company (BV).
When was DR. CHRISTOPHE LEBRUN founded?
DR. CHRISTOPHE LEBRUN was founded on 27-04-2015.
Is DR. CHRISTOPHE LEBRUN still active?
Yes, DR. CHRISTOPHE LEBRUN is an active enterprise in the KBO register.
What is the turnover of DR. CHRISTOPHE LEBRUN?
The turnover in financial year 2025 is ≈ €140,000. This figure is estimated from the gross margin of €63,459 and 32 comparable companies (NACE 862). It probably lies between €110,000 and €180,000.Financials
Is DR. CHRISTOPHE LEBRUN profitable?
In financial year 2025, DR. CHRISTOPHE LEBRUN made a profit of €45,190.
Where can I find the annual accounts of DR. CHRISTOPHE LEBRUN?
DR. CHRISTOPHE LEBRUN filed 11 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of DR. CHRISTOPHE LEBRUN due?
DR. CHRISTOPHE LEBRUN must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.